Armistice Capital’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SM
Armistice Capital's MTRI Position: Q2 2024 in Review
Armistice Capital sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q2 2024, closing a stake of 1,335 shares — an estimated $97.2K sold.
Armistice Capital first reported a position in MTRI in Q1 2021 and held it in 8 quarters. The position peaked at $2.83M in Q2 2021. 7 funds tracked by Wall St. Rank hold MTRI as of Q2 2024.
- Armistice Capital reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Armistice Capital sold 1,335 Mentari Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $97.2K.
- Armistice Capital first reported a position in Mentari Therapeutics, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
- Armistice Capital's Mentari Therapeutics, Inc. Common Stock position peaked at $2.83M in Q2 2021.
- 7 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q2 2024.
Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.